Skip to content

Prefabricated CAD CAM Allogeneic Ring Blocks in the Anterior Maxilla With Immediate Implantation

Prefabricated CAD CAM Allogeneic Ring Blocks in the Anterior Maxilla With Immediate Implantation a Prospective Single-Arm Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07163351
Enrollment
20
Registered
2025-09-09
Start date
2024-01-01
Completion date
2025-07-01
Last updated
2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogeneic Ring Blocks, Anterior Maxilla, CAD, CAM, Immediate Implantation, Prefabricated

Brief summary

Clinical and radiographic evaluation of a new modification of ring technique using omputeraided design/computer-aided manufacturing (CAD/CAM) milling of allogeneic bone block for anterior maxilla ridge augmentation with immediate implantation

Detailed description

Dental implant failure remains a clinically significant challenge, with early failures typically attributed to insufficient osseointegration, surgical trauma, bacterial contamination, or micromotion during healing. In contrast, late failures are often associated with occlusal overload, peri-implantitis, or implant mispositioning. These challenges have driven the adoption of allogeneic bone blocks, particularly those fabricated using computeraided design/computer-aided manufacturing (CAD/CAM) technology, which offer precise anatomical adaptation, reduced surgical time, and minimized complications compared to manual grafting techniques

Interventions

OTHERCAD/CAM allogenic bone block

CAD/CAM allogenic bone block augmentation with immediate non-functional implant loading

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 65 years. * Both sexes. * Patients presenting with anterior maxillary alveolar bone defects resulting from previous implant failure. * Systemically healthy individuals, classified as American Society of Anesthesiologists (ASA) physical status I or II. * Participants were either non-smokers or light smokers consuming fewer than 10 cigarettes per day.

Exclusion criteria

* Uncontrolled systemic conditions such as diabetes mellitus or osteoporosis. * Pregnant or breastfeeding at the time of recruitment. * Individuals with a history of head or neck radiation therapy. * Cases in which insufficient bone volume for implant placement persisted following augmentation.

Design outcomes

Primary

MeasureTime frameDescription
Vertical/Horizonal Bone Gain18 months post-procedureVertical/Horizonal Bone Gain was measured via cone beam computed tomography superimposition at 18 months

Secondary

MeasureTime frameDescription
Implant Survival Rate18 months post-procedureImplant survival rate, defined as the absence of clinical mobility, peri-implant infection, persistent pain, or radiographic evidence of peri-implant radiolucency or bone loss beyond expected physiological remodelling. Implant stability was assessed clinically using percussion and mobility tests, and radiographically using periapical radiographs and/or cone-beam computed tomography at designated follow-up intervals. Survival was evaluated at 6, 12, and 18 months postoperatively
Assessment of aesthetic outcome18 months post-procedureAssessment of aesthetic outcome were assessed using the Pink Esthetic Score (PES), a validated clinical index that evaluates seven soft tissue parameters around the implant site: mesial and distal papillae, soft tissue level, soft tissue contour, alveolar process deficiency, soft tissue color, and texture. PES was evaluated at 12 and 18 months by two calibrated examiners blinded to the treatment allocation.
Patient Satisfaction18 months post-procedurePatient-reported satisfaction with the aesthetic and functional outcomes was measured using a 10-point Visual Analog Scale (VAS). Patients were asked to rate their satisfaction with the final restoration, including perceived appearance, comfort, and chewing efficiency at 12 and 18 months postoperatively. Mean VAS scores were analyzed and compared over time.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026